Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens

Therapeutic options for the treatment of colorectal cancer (CRC) are diverse but still not always satisfying. Recent success of immune checkpoint inhibition treatment for the subgroup of CRC patients suffering from hyper-mutated tumors suggests a permanent role of immune therapy in the clinical mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Sandra, Mullins, Christina S, Linnebacher, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319136/
https://www.ncbi.nlm.nih.gov/pubmed/30622371
http://dx.doi.org/10.3748/wjg.v24.i48.5418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319136/
https://www.ncbi.nlm.nih.gov/pubmed/30622371
http://dx.doi.org/10.3748/wjg.v24.i48.5418

Ejemplares similares